Skip to main content

Published locations for FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancer

User login

  • Reset your password
  • /content/fda-oks-combo-therapy-niraparib-abiraterone-acetate-prostate-cancer
  • /fedprac/article/264673/genitourinary-cancer/fda-oks-combo-therapy-niraparib-abiraterone-acetate
  • /oncologypractice/article/264673/genitourinary-cancer/fda-oks-combo-therapy-niraparib-abiraterone
  • /fedprac/avaho/article/264673/genitourinary-cancer/fda-oks-combo-therapy-niraparib-abiraterone
  • /hematology-oncology/article/264673/genitourinary-cancer/fda-oks-combo-therapy-niraparib-abiraterone